Citadel Advisors’s Pfizer PFE Stock Holding History

Citadel Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$252M	Sell	8,992,100 -1,021,600	-10%	-$27.2M	0.04%	358
2025 Q4	$249M	Buy	10,013,700 +2,737,800	+38%	+$69M	0.04%	405
2025 Q3	$185M	Sell	7,275,900 -5,588,800	-43%	-$138M	0.03%	513
2025 Q2	$312M	Sell	12,864,700 -2,926,900	-19%	-$68.3M	0.05%	270
2025 Q1	$400M	Sell	15,791,600 -1,985,100	-11%	-$51.9M	0.08%	176
2024 Q4	$472M	Buy	17,776,700 +5,746,800	+48%	+$156M	0.08%	161
2024 Q3	$348M	Sell	12,029,900 -74,100	-0.6%	-$2.16M	0.07%	208
2024 Q2	$339M	Buy	12,104,000 +2,558,300	+27%	+$70.4M	0.07%	206
2024 Q1	$265M	Buy	9,545,700 +1,492,100	+19%	+$41.4M	0.05%	280
2023 Q4	$232M	Sell	8,053,600 -5,555,700	-41%	-$168M	0.05%	297
2023 Q3	$451M	Buy	13,609,300 +6,418,200	+89%	+$227M	0.1%	114
2023 Q2	$264M	Buy	7,191,100 +1,908,300	+36%	+$74.3M	0.05%	225
2023 Q1	$216M	Sell	5,282,800 -3,422,900	-39%	-$148M	0.05%	289
2022 Q4	$446M	Sell	8,705,700 -1,361,800	-14%	-$65.3M	0.1%	130
2022 Q3	$441M	Sell	10,067,500 -162,500	-2%	-$7.9M	0.1%	112
2022 Q2	$536M	Sell	10,230,000 -2,065,200	-17%	-$105M	0.14%	81
2022 Q1	$637M	Sell	12,295,200 -613,200	-5%	-$31.8M	0.13%	76
2021 Q4	$762M	Buy	12,908,400 +7,067,400	+121%	+$350M	0.16%	62
2021 Q3	$251M	Sell	5,841,000 -1,561,500	-21%	-$69.2M	0.05%	270
2021 Q2	$290M	Buy	7,402,500 +2,895,400	+64%	+$113M	0.06%	208
2021 Q1	$163M	Sell	4,507,100 -2,869,600	-39%	-$102M	0.04%	368
2020 Q4	$272M	Buy	7,376,700 +2,648,878	+56%	+$97.2M	0.07%	171
2020 Q3	$165M	Buy	4,727,822 +2,340,512	+98%	+$82.1M	0.05%	255
2020 Q2	$74.1M	Sell	2,387,310 -1,212,100	-34%	-$41.2M	0.03%	556
2020 Q1	$111M	Buy	3,599,410 +1,195,868	+50%	+$40.7M	0.05%	303
2019 Q4	$89.3M	Sell	2,403,542 -972,631	-29%	-$34.6M	0.04%	450
2019 Q3	$115M	Buy	3,376,173 +1,098,268	+48%	+$39.9M	0.05%	348
2019 Q2	$93.6M	Sell	2,277,905 -213,856	-9%	-$8.49M	0.04%	422
2019 Q1	$100M	Buy	2,491,761 +360,151	+17%	+$14.4M	0.05%	362
2018 Q4	$88.3M	Buy	2,131,610 +200,260	+10%	+$8.31M	0.05%	364
2018 Q3	$80.8M	Sell	1,931,350 -267,821	-12%	-$10.3M	0.04%	500
2018 Q2	$75.7M	Buy	2,199,171 +720,093	+49%	+$24.6M	0.04%	485
2018 Q1	$49.8M	Buy	1,479,078 +72,726	+5%	+$2.5M	0.03%	606
2017 Q4	$48.3M	Sell	1,406,352 -353,512	-20%	-$12.1M	0.03%	634
2017 Q3	$59.6M	Sell	1,759,864 -468,081	-21%	-$15M	0.05%	458
2017 Q2	$71M	Sell	2,227,945 -825,704	-27%	-$26M	0.06%	351
2017 Q1	$99.1M	Buy	3,053,649 +246,004	+9%	+$7.76M	0.09%	203
2016 Q4	$86.5M	Buy	2,807,645 +1,056,319	+60%	+$32.2M	0.09%	204
2016 Q3	$56.3M	Sell	1,751,326 -1,046,939	-37%	-$35M	0.06%	336
2016 Q2	$93.5M	Buy	2,798,265 +1,385,800	+98%	+$44.2M	0.1%	158
2016 Q1	$39.7M	Buy	1,412,465 +431,191	+44%	+$12.3M	0.05%	392
2015 Q4	$30.1M	Sell	981,274 -528,476	-35%	-$16.6M	0.03%	615
2015 Q3	$45M	Buy	1,509,750 +706,918	+88%	+$22.7M	0.04%	484
2015 Q2	$25.5M	Buy	802,832 +79,577	+11%	+$2.59M	0.02%	851
2015 Q1	$23.9M	Sell	723,255 -3,478	-0.5%	-$111K	0.02%	885
2014 Q4	$21.5M	Sell	726,733 -59,024	-8%	-$1.69M	0.02%	894
2014 Q3	$22M	Sell	785,757 -300,601	-28%	-$8.44M	0.02%	853
2014 Q2	$30.6M	Buy	1,086,358 +388,715	+56%	+$11.1M	0.04%	596
2014 Q1	$21.3M	Sell	697,643 -402,311	-37%	-$12M	0.02%	788
2013 Q4	$32M	Buy	1,099,954 +194,779	+22%	+$5.67M	0.04%	554
2013 Q3	$24.7M	Buy	905,175 +156,624	+21%	+$4.26M	0.04%	622
2013 Q2	$19.9M	Buy	+748,551	New	+$20.7M	0.03%	663

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Citadel Advisors's PFE Position: Q1 2026 in Review

Citadel Advisors increased its Pfizer (PFE) stake by 36% in Q1 2026, buying an estimated $52M and bringing the position to 7,359,865 shares worth $207M. The position accounts for 0.03% of the portfolio, ranked #443.

Citadel Advisors first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $571M in Q2 2024. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Citadel Advisors held 7,359,865 shares of Pfizer worth $207M as of Q1 2026.
Citadel Advisors bought 1,952,489 Pfizer shares in Q1 2026, an estimated $52M.
Pfizer made up 0.03% of Citadel Advisors's portfolio in Q1 2026, its #443 holding.
Citadel Advisors first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
Citadel Advisors's Pfizer position peaked at $571M in Q2 2024.
2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.